Treatment of imatinib resistant leukemia using 4-aminoquinoline-3-carbonitriles
摘要
<p>The present invention provides 4-aminoquinoline 3-carbonitrile compounds useful for treating a subject having an BcrAbl positive leukemia that is resistant to imatinib.</p>